SkinBioTherapeutics (SBTX)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

 16.75p
   
  • Change Today:
      0.000p
  • 52 Week High: 26.10
  • 52 Week Low: 12.25
  • Currency: UK Pounds
  • Shares Issued: 258.78m
  • Volume: 0
  • Market Cap: £43.35m
  • Beta: 0.51

Latest Deals

No deals were found in the last 365 days.

Largest Deals (365 days)

No deals were found in the last 365 days.

Director Shareholdings

Notifier Holding Value*
Martin Braddock Hunt 466,667 £78,167
Stuart Ashman 455,060 £76,223
Catherine Denise Prescott 118,612 £19,868

Major Shareholders

Notifier** Holding Value*
Mark H Dixon 39,000,000 £6,532,500
David Campbell Brierwood 16,416,813 £2,749,816
Seneca Partners Limited 15,604,406 £2,613,738
OptiBiotix Health 14,600,000 £2,445,500
Tyndall Investment Management 13,165,553 £2,205,230
Tyndall Investment Management 13,165,553 £2,205,230
Unicorn Asset Management Limited 7,894,736 £1,322,368
Andrew McBain 4,301,433 £720,490

* Value is calculated by using the current share price multiplied by the amount held.
** Major Shareholders are individuals or institutions that own more than 3% of the company’s shares and have been reported in the annual accounts.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

SBTX Market Data

Currency UK Pounds
Share Price 16.75p
Change Today 0.000p
% Change 0.00 %
52 Week High 26.10
52 Week Low 12.25
Volume 0
Shares Issued 258.78m
Market Cap £43.35m
Beta 0.51

SBTX Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
71.12% below the market average71.12% below the market average71.12% below the market average71.12% below the market average71.12% below the market average
75.61% below the sector average75.61% below the sector average75.61% below the sector average75.61% below the sector average75.61% below the sector average
Price Trend
36.07% below the market average36.07% below the market average36.07% below the market average36.07% below the market average36.07% below the market average
9.09% below the sector average9.09% below the sector average9.09% below the sector average9.09% below the sector average9.09% below the sector average
Income Not Available
Growth
49.92% above the market average49.92% above the market average49.92% above the market average49.92% above the market average49.92% above the market average
72.41% above the sector average72.41% above the sector average72.41% above the sector average72.41% above the sector average72.41% above the sector average

SBTX Dividends

No dividends found

Trades for --2026

Time Volume / Share Price
0 @ 0.000p

SBTX Key Personnel

CEO Stuart Ashman

Top of Page